Brown CM, et al. Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings -- Barnstable County, Massachusetts, July 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1059-1062.
Centers for Disease Control and Prevention. Interim Public Health Recommendations for Fully Vaccinated People. Updated July 28, 2021. Accessed August 21, 2021. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated-guidance.html
Centers for Disease Control and Prevention. Vaccination and Case Trends of COVID-19 in the United States. Accessed August 21, 2021. https://covid.cdc.gov/covid-data-tracker/#vaccinations-cases-trends
Israel A, et al. Elapsed time since BNT162b2 vaccine and risk of SARS-CoV-2 infection in a large cohort. medRxiv. 2021 Aug 5:2021.08.03.21261496. https://www.medrxiv.org/content/10.1101/2021.08.03.21261496v1
Kamar N, et al. Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients. N Engl J Med. 2021;385:661-662.
KFF. COVID-19 vaccine breakthrough cases: data from the states. July 30, 2021. Accessed August 21, 2021. https://www.kff.org/policy-watch/covid-19-vaccine-breakthrough-cases-data-from-the-states/
Pfizer, Inc. Pfizer and BioNTech provide update on booster program in light of the delta-variant. News release. July 8, 2021. Accessed August 21, 2021. https://cdn.pfizer.com/pfizercom/2021-07/Delta_Variant_Study_Press_Statement_Final_7.8.21.pdf
Press Briefing by White House COVID-⁠19 Response Team and Public Health Officials, July 1, 2021. Accessed August 21, 2021. https://www.whitehouse.gov/briefing-room/press-briefings/2021/07/01/press-briefing-by-white-house-covid-19-response-team-and-public-health-officials-43/
The WHO is right to call a temporary halt to COVID vaccine boosters [no authors listed]. Nature. 2021;596:317.
US Food and Drug Administration. FDA approves first COVID-19 vaccine. News release. August 23, 2021. Accessed September 23, 2021. https://www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine
US Food and Drug Administration. Janssen COVID-19 vaccine EUA FDA review memorandum. Accessed August 21, 2021. https://www.fda.gov/media/146338/download
US Food and Drug Administration. Moderna COVID-19 vaccine EUA FDA review memorandum. Accessed August 21, 2021. https://www.fda.gov/media/144673/download
US Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine EUA amendment review memorandum. Accessed August 21, 2021. https://www.fda.gov/media/148542/download
White House Briefing Room Fact Sheet, May 4, 2021. Accessed August 19, 2021. https://www.whitehouse.gov/briefing-room/statements-releases/2021/05/04/fact-sheet-president-biden-to-announce-goal-to-administer-at-least-one-vaccine-shot-to-70-of-the-u-s-adult-population-by-july-4th/

As an organization accredited by the ACCME, Medscape, LLC requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Faculty

Daniel Griffin, MD, PhD

Clinical Professor of Medicine
Columbia University
Chief, Infectious Disease
ProHEALTH New York
Senior Fellow for Infectious Disease
UnitedHealth Group
New York, New York

Disclosures

Disclosure: Daniel Griffin, MD, PhD, has no relevant financial relationships.

Editor

Maria B. Uravich, BSc, ELS

Senior Medical Education Director, Medscape, LLC

Maria B. Uravich, BSc, ELS Senior Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Maria B. Uravich, BSc, ELS, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

None of the nonfaculty planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

CME / ABIM MOC / CE

COVID-19 Vaccine Updates: Epidemiology and Vaccination

Authors: Daniel Griffin, MD, PhD
CME / ABIM MOC / CE Released: 9/27/2021
THIS ACTIVITY HAS EXPIRED FOR CREDIT
Valid for credit through: 9/27/2022, 11:59 PM EST

Start Activity

Target Audience and Goal Statement

This activity is intended for primary care physicians, obstetricians, gynecologists, diabetologists, endocrinologists and nurses.

The goal of this activity is to keep clinicians current on the status of the COVID-19 vaccine campaign and the impact of vaccines on epidemiology of the disease.

Upon completion of this activity, participants will:

Have increased knowledge regarding the
- Current trends in the epidemiology of COVID-19
- Status of COVID-19 vaccination in the US

Disclosures

Faculty

Daniel Griffin, MD, PhD

Clinical Professor of Medicine
Columbia University
Chief, Infectious Disease
ProHEALTH New York
Senior Fellow for Infectious Disease
UnitedHealth Group
New York, New York

Disclosures

Disclosure: Daniel Griffin, MD, PhD, has no relevant financial relationships.

Editor

Maria B. Uravich, BSc, ELS

Senior Medical Education Director, Medscape, LLC

Maria B. Uravich, BSc, ELS Senior Medical Education Director, Medscape, LLC

Disclosures

Disclosure: Maria B. Uravich, BSc, ELS, has disclosed no relevant financial relationships.

CME Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Associate Director, Accreditation and Compliance, Medscape, LLC

Disclosures

Disclosure: Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP, has disclosed no relevant financial relationships.

Accreditation Statements

In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians

Medscape, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.25 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Aggregate participant data will be shared with commercial supporters of this activity.

Contact This Provider

For Nurses

Awarded 0.25 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.25 contact hours are in the area of pharmacology.

Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]

Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

Read the target audience, learning objectives, and author disclosures.
Study the educational content online or printed out.
Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

COVID-19 Vaccine Updates

From Medscape Education Family Medicine

CME / ABIM MOC / CE

COVID-19 Vaccine Updates: Epidemiology and Vaccination

Authors: Daniel Griffin, MD, PhDFaculty and Disclosures

THIS ACTIVITY HAS EXPIRED FOR CREDIT

CME / ABIM MOC / CE Released: 9/27/2021

Valid for credit through: 9/27/2022, 11:59 PM EST

processing....

Note: The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication. We continue to add to the collection of activities on this subject as new information becomes available. It is the policy of Medscape Education to avoid the mention of brand names or specific manufacturers in accredited educational activities. However, manufacturer names related to COVID-19 vaccines are provided in this activity in an effort to promote clarity. The use of manufacturer names should not be viewed as an endorsement by Medscape of any specific product or manufacturer.

CME / ABIM MOC / CE Information

Activity Transcript

Print
Like Tweet

Disclaimer

The educational activity presented above may involve simulated, case-based scenarios. The patients depicted in these scenarios are fictitious and no association with any actual patient, whether living or deceased, is intended or should be inferred. The material presented here does not necessarily reflect the views of Medscape, LLC, or any individuals or commercial entities that support companies that support educational programming on medscape.org. These materials may include discussion of therapeutic products that have not been approved by the US Food and Drug Administration, off-label uses of approved products, or data that were presented in abstract form. These data should be considered preliminary until published in a peer-reviewed journal. Readers should verify all information and data before treating patients or employing any therapies described in this or any educational activity. A qualified healthcare professional should be consulted before using any therapeutic product discussed herein.

References

Faculty and Disclosures

Faculty

Daniel Griffin, MD, PhD

Editor

Maria B. Uravich, BSc, ELS

CME Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

CME / ABIM MOC / CE

COVID-19 Vaccine Updates: Epidemiology and Vaccination

Target Audience and Goal Statement

Disclosures

Faculty

Daniel Griffin, MD, PhD

Editor

Maria B. Uravich, BSc, ELS

CME Reviewer/Nurse Planner

Leigh Schmidt, MSN, RN, CMSRN, CNE, CHCP

Accreditation Statements

For Physicians

For Nurses

Instructions for Participation and Credit

COVID-19 Vaccine Updates: Epidemiology and Vaccination